Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific EGFR/c-Met antibodies

Bispecific EGFR/c-Met antibodies

US Patent 9593164 · Granted Mar 14, 2017

Estimated economic value: $58,238,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapies with bispecific anti-EGFR/c-met antibodies and third gener2025
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Antibodies that bind PSMA and gamma-delta T cell receptors2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents binding to EpCAM and CD1372025
Antibody variant combinations and uses thereof2025
Agent, uses and methods for treatment2025
EGFR and C-met fibronectin type III domain binding molecules2025
Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use t2025
Method for producing a controlled mixture of two or more different antibodies2025
Method for producing a controlled mixture of two or more different antibodies2025
Bispecific EGFR/c-Met antibodies2025